Postgraduate - UnitECC5971 - Pharmaceutical economics

This unit entry is for students who completed this unit in 2014 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 3, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

Level	Postgraduate
Faculty	Faculty of Business and Economics
Organisational Unit	Department of Economics
Offered	Clayton Second semester 2014 (Off-campus)
Coordinator(s)	Dr Silva Zavarsek

Synopsis

The economics of the pharmaceutical industry including the market for pharmaceuticals and its regulation internationally and in Australia. Principles of economic evaluation of the costs and outcomes of pharmaceutical products, and provides a guide to best practice with particular emphasis on clinical trials and protocol design.

Outcomes

The learning goals associated with this unit are to:

economic analysis in the pharmaceutical industry
structure of the pharmaceutical industry and the inter-relationship between the nature of the product, market structure and government regulation
impact of government intervention in the pharmaceutical industry including alternative regulatory regimes
role of economic evaluation in promoting the efficient use of drugs
economic analysis of drugs alongside clinical trials, including techniques of health outcome measurement.

Assessment

Within semester assessment: 70%
Examination: 30%

Chief examiner(s)

Dr Silva Zavarsek

Prohibitions

ECX9710